New York, Jan 9, 2021- Researchers have developed a nanoparticle vaccine that elicits a virus-neutralising antibody response after a single dose. The team, including Peter Kim from Stanford University in the US, said that the primary target for Covid-19 vaccines is the spike protein, which is necessary for SARS-CoV-2’s entry into cells. Both of the … Continue reading Single-dose Covid vaccine triggers antibody response: Study